about
Computational Approaches for the Discovery of Human Proteasome Inhibitors: An OverviewThe 26S proteasome is a multifaceted target for anti-cancer therapiesIndolo-phakellins as β5-specific noncovalent proteasome inhibitorsIdentification of a β1/β2-specific sulfonamide proteasome ligand by crystallographic screeningOxadiazole-isopropylamides as potent and noncovalent proteasome inhibitors.Recent advances in proteasome inhibitor discovery.Inhibition of human and yeast 20S proteasome by analogues of trypsin inhibitor SFTI-1Substituted quinolines as noncovalent proteasome inhibitors.Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes.Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity.Proteasome inhibitors: an expanding army attacking a unique target.Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development.Synthesis and pharmacology of proteasome inhibitors.Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome systemPharmacophore modeling technique applied for the discovery of proteasome inhibitors.Synthesis, bioactivity, docking and molecular dynamics studies of furan-based peptides as 20S proteasome inhibitors.Structural Elucidation of a Nonpeptidic Inhibitor Specific for the Human Immunoproteasome.Immunoproteasome β5i-Selective Dipeptidomimetic Inhibitors.
P2860
Q26738752-5E5D9110-18AF-4BEF-A31A-665F4AA9E573Q26795764-9A3342C0-819E-4574-BEC2-79171B448FBDQ27697335-29896FB8-6195-41E7-8C3C-B89DDD9DF6AFQ27701726-F5ED70DB-6807-4D5D-B511-5F41575FB20CQ34644848-8B663353-A49F-4EA1-93D3-19556C37CA77Q34645067-1BEC7C14-447A-4C40-863F-10850FDBC3D3Q35107386-F7610E89-2580-4AFF-A409-4960098DC148Q35998619-F1168A9A-C7A8-4A14-9262-6DACC6747EA6Q37705854-BA3F2F95-152A-4034-B457-4EC44F015FE7Q37727613-0BEF9E16-6E57-45B3-8DDE-23B4DBEEE215Q37979388-5FB887C6-A712-445E-AA6F-ACFA9C547ED6Q38019864-D7FAF058-66CE-48F7-A628-E471AC8FF892Q38092777-D536D545-E0CA-45A4-A6E5-06CC9037C787Q38181445-6D479211-171F-4038-A653-828B790403EEQ38216045-CE818DF1-95F2-464A-A46C-5A35F2DA379CQ38914094-4C13C8ED-BA39-4769-ACFD-847F4611F097Q48340774-F88484A8-3C64-4686-AAA5-4C13B0FDB676Q49181404-41D60EDE-C0FE-4890-85C7-915CF639A0DD
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Hydroxyureas as noncovalent proteasome inhibitors
@ast
Hydroxyureas as noncovalent proteasome inhibitors
@en
Hydroxyureas as noncovalent proteasome inhibitors
@nl
type
label
Hydroxyureas as noncovalent proteasome inhibitors
@ast
Hydroxyureas as noncovalent proteasome inhibitors
@en
Hydroxyureas as noncovalent proteasome inhibitors
@nl
prefLabel
Hydroxyureas as noncovalent proteasome inhibitors
@ast
Hydroxyureas as noncovalent proteasome inhibitors
@en
Hydroxyureas as noncovalent proteasome inhibitors
@nl
P2093
P2860
P356
P1476
Hydroxyureas as noncovalent proteasome inhibitors
@en
P2093
Marcelino Arciniega
Nerea Gallastegui
Robert Huber
Stefan Hillebrand
P2860
P356
10.1002/ANIE.201106010
P407
P577
2012-01-02T00:00:00Z